BioNTech SE (BNTX) Current Taxes (2018 - 2025)
BioNTech SE (BNTX) posted Current Taxes of $76.4 million for Q4 2025, up 936.81% sequentially from $7.4 million in Q3 2025, and up 1487.99% YoY from $4.8 million in Q4 2024.
BioNTech SE (BNTX) Current Taxes (2018 - 2025) Analysis & Trends
BioNTech SE has reported Current Taxes for 7 years, with the latest figure at $76.4 million in Q4 2025.
- Quarterly Current Taxes rose 1487.99% year-over-year to $76.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $76.4 million (up 1487.99% YoY) and the FY2025 annual result came in at $74.1 million, up 1441.29% from the prior year.
- Current Taxes rose to $76.4 million in Q4 2025 per BNTX's latest filing, from $7.4 million in the prior quarter.
- Over five years, Current Taxes peaked at $1.8 billion in Q1 2022 and troughed at $4.2 million in Q2 2025.
- A 5-year average of $629.2 million and a median of $565.2 million in 2023 frame the typical range for Current Taxes.
- The sharpest annual moves came in 2024 and 2025: Current Taxes slumped 99.15% in 2024, then soared 1487.99% in 2025.
- Over 5 years, Current Taxes stood at $1.8 billion in 2021, then slumped by 66.13% to $608.0 million in 2022, then decreased by 7.0% to $565.4 million in 2023, then tumbled by 99.15% to $4.8 million in 2024, then surged by 1487.99% to $76.4 million in 2025.
- According to Business Quant data, Current Taxes over the past three periods registered $76.4 million, $7.4 million, and $4.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn | 76.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 76.36 Mn |
| Sep 30, 2025 | 7.37 Mn |
| Jun 30, 2025 | 4.19 Mn |
| Mar 31, 2025 | 5.68 Mn |
| Dec 31, 2024 | 4.81 Mn |
| Sep 30, 2024 | 399.31 Mn |
| Jun 30, 2024 | 393.28 Mn |
| Mar 31, 2024 | 383.70 Mn |
| Dec 31, 2023 | 565.41 Mn |
| Sep 30, 2023 | 593.50 Mn |
| Jun 30, 2023 | 604.24 Mn |
| Mar 31, 2023 | 564.90 Mn |
| Dec 31, 2022 | 607.97 Mn |
| Sep 30, 2022 | 1.40 Bn |
| Jun 30, 2022 | 1.51 Bn |
| Mar 31, 2022 | 1.81 Bn |
| Dec 31, 2021 | 1.79 Bn |
| Mar 31, 2021 | 596.97 Mn |
| Dec 31, 2019 | 166,033.15 |
| Sep 30, 2019 | 330,480.82 |